Form SC 13G HALOZYME THERAPEUTICS Filed by: BB BIOTECH AG
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140807/AB22922FZ22ROJZ2222T2ZXSKMT4OZ223262
Filed on: August 7, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark Reiterates Buy Rating on Halozyme Therapeutics (HALO) on 'Solid Partnership Momentum'
- Halozyme to Report Second Quarter 2026 Financial and Operating Results
- Halozyme and Incyte sign drug delivery licensing agreement
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
